Biology of Blood and Marrow Transplantation
Volume 16, Issue 9 , Pages 1265-1271 , September 2010

Detection and Control of a Nosocomial Respiratory Syncytial Virus Outbreak in a Stem Cell Transplantation Unit: The Role of Palivizumab

  • Christelle Kassis

      Affiliations

    • Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Richard E. Champlin

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
    • ,
  • Ray Y. Hachem

      Affiliations

    • Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Chitra Hosing

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
    • ,
  • Jeffrey J. Tarrand

      Affiliations

    • Department of Laboratory Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Cheryl A. Perego

      Affiliations

    • Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Joyce L. Neumann

      Affiliations

    • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas
    • ,
  • Issam I. Raad

      Affiliations

    • Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • Roy F. Chemaly

      Affiliations

    • Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • Corresponding Author InformationCorrespondence and reprint requests: Roy F. Chemaly, MD, MPH, Department of Infectious Disease, Infection Control and Employee Health, Unit 402, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030.

Received 8 January 2010 ,Accepted 10 March 2010.

References 

  1. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342:232–239
  2. Falsey AR, Treanor JJ, Betts RF, et al. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc. 1992;40:115–119
  3. Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;282:1440–1446
  4. Fenton C, Scott LJ, Plosker GL. Palivizumab: a review of its use as prophylaxis for serious respiratory syncytial virus infection. Paediatr Drugs. 2004;6:177–197
  5. Sable CA, Hayden FG. Orthomyxoviral and paramyxoviral infections in transplant patients. Infect Dis Clin N Am. 1995;9:987–1003
  6. Whimbey E, Champlin R, Englund J, et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant. 1995;16:393
  7. Falsey AR, Hennessey PA, Formica MA, et al. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352:1749–1759
  8. Osterweil D, Norman D. An outbreak of an influenza-like illness in a nursing home. J Am Geriatr Soc. 1990;38:659–662
  9. Falsey AR. Noninfluenza respiratory virus infection in long-term care facilities. Infect Control Hosp Epidemiol. 1991;12:602–608
  10. Abdallah A, Rowland KE, Schepetiuk SK, To LB, Bardy P. An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: effect on engraftment and outcome of pneumonia without specific antiviral treatment. Bone Marrow Transplant. 2003;32:195–203
  11. Harrington RD, Hooton TM, Hackman RC, et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis. 1992;165:987–993
  12. Jalal H, Bibby DF, Bennett J, et al. Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit. J Clin Microbiol. 2007;1690–1696
  13. Isaacs D, Dickson H, O'Callaghan C, Sheaves R, Winter A, Moxon ER. Handwashing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus. Arch Dis Child. 1991;66:227–231
  14. Madge P, Paton JY, McColl JH, Mackie PL. Prospective controlled study of four infection control procedures to prevent nosocomial infection with respiratory syncytial virus. Lancet. 1992;340:1079–1083
  15. American Academy of Pediatrics Committee on Infectious Diseases, Committee on Foetus and Newborn. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IG IV. Pediatrics. 1998;102:1211–1216
  16. Carbonell X, Giuffre L, Kimpen J, et al. Guidelines for the use of Synagis palivizumab—a humanized monoclonal antibody, for the prevention of RSV disease in high-risk infants: a consensus opinion. Infect Med. 1999;16:1–5
  17. Meissner HC, Welliver RC, Chartrand SA, et al. Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion. Pediatr Infect Dis J. 1999;18:223–231
  18. Landry ML, Ferguson D. SimuFluor respiratory screen for rapid detection of multiple respiratory viruses in clinical specimens by immunofluorescence staining. J Clin Microbiol. 2000;38:708–711
  19. Couch RB, Englund JA, Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med. 1997;102:2–9
  20. Chemaly RF, Ghosh S, Bodey GP, et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore). 2006;85:278–287
  21. Raboni SM, Nogueira MB, Tsuchiya LR, et al. Respiratory tract viral infections in bone marrow transplant patients. Transplantation. 2003;76:142–146
  22. Whimbey E, Englund JA, Couch RB. Community respiratory virus infections in immunocompromised patients with cancer. Am J Med. 1997;102:10–18
  23. Ghosh S, Champlin RE, Englund J, et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant. 2000;25:751–755
  24. Hall CB, Douglas RG. Modes of transmission of RSV. J Pediatr. 1981;99:100
  25. Hall CB, Douglas RG, Schnabel KC, Geiman JM. Infectivity of respiratory RSV by various routes of inoculation. Infect Immun. 1982;33:779
  26. Hall CB, Douglas RG, Geiman JM. Quantitative shedding patterns of respiratory syncytial virus in infants. J Infect Dis. 1975;132:151
  27. Gala CL, Hall CB, Schnabel KC, et al. The use of eye nose goggles to control nosocomial respiratory syncytial virus infection. JAMA. 1986;256:2706
  28. Tablan OC, Anderson LJ, Besser R, et al. Guidelines for preventing health care-associated pneumonia, 2003: recommendations of CDC and healthcare infection control practice advisory committee. MMWR Recomm Rep. 2004;53:1
  29. Krasinski K, LaCouture R, Holzman RS, et al. Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmission. J Pediatr. 1990;116:894
  30. Abadesso C, Almeida HI, Virella D, Carreiro MH, Machado MC. Use of palivizumab to control an outbreak of syncytial respiratory virus in a neonatal intensive care unit. J Hospital Infect. 2004;58:38–41
  31. Scott LJ, Lamb HM. Palivizumab. Drugs. 1999;58:305–311
  32. The Impact-RSV Study Group . Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102:531–537
  33. Singelton R, Dooley L, Bruden D, et al. Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants. Pediatr Infect Dis J. 2003;22(6):540–555
  34. Palivizumab Outcomes Study Group . Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes Registry. Pediatr Pulmonol. 2003;35:484–489
  35. Cohen AH, Sorrentino M, Powers T. Effectiveness of palivizumab for preventing serious RSV disease. J Respir Dis. 2000;2:S30–S32
  36. Lacaze-Masmonteil T, Rozé JC, Fauroux B. French Pediatricians' Group of Synagis Patients' Name-Based Programs. Incidence of respiratory syncytial virus-related hospitalizations in high-risk children: follow-up of a national cohort of infants treated with palivizumab as RSV prophylaxis. Pediatr Pulmonol. 2002;34:181–188
  37. Pedraz C, Carbonell-Estrany X, Figueras-Aloy J, et al. Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants. Pediatr Infect Dis J. 2003;22:823–827
  38. Grimaldi M, Gouyon B, Sagot P, et al. Palivizumab efficacy in preterm infants with gestational age < or = 30 weeks without bronchopulmonary dysplasia. Pediatr Pulmonol. 2007;42:189–192
  39. Cohen SA, Zanni R, Cohen A, et al. Palivizumab use in subjects with congenital heart disease: results from the 2000-2004 Palivizumab Outcomes Registry. Pediatr Cardiol. 2008;29:382–387
  40. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn . Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003;12:1442–1446
  41. Thomas NJ, Hollenbeak CS, Ceneviva GD, et al. Palivizumab prophylaxis to prevent respiratory syncytial virus mortality after pediatric bone marrow transplantation: a decision analysis model. J Pediatr Hematol Oncol. 2007;29:227–232
  42. Boeckh M, Berrey MM, Bowden RA, et al. Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. J Infect Dis. 2001;184:350–354
  43. Georgescu G, Chemaly RF. Palivizumab: where to from here?. Expert Opin Biol Ther. 2009;9:139–147
  44. Forbes M. Strategies for preventing respiratory syncytial virus. Am J Health Syst Pharm. 2008;65(Suppl 8):
  45. Salcedo S, Vinzo J, Calico I, et al. Administration of palivizumab during a nosocomial outbreak in a neonatal unit Abstract P241, presented at the XVII European Congress of Perinatal Medicine, Porto Portugal. Prenatal Neonatal Med. 2000;5:180
  46. Cox RA, Rao P, Brandon-Cox C. The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit. J Hosp Infect. 2001;48:186–192
  47. Kilani RA. Respiratory syncytial virus (RSV) outbreak in the NICU: description of eight cases. J Trop Pediatr. 2002;48:118–122
  48. Heerens AT, Marshall DD, Bose CL. Nosocomial respiratory syncytial virus: a threat in the modern neonatal intensive care unit. J Perinatol. 2002;22:306–307
  49. Halasa NB, Williams JV, Wilson GJ, et al. Medical and economic impact of a respiratory syncytial virus outbreak in a neonatal intensive care unit. Pediatr Infect Dis J. 2005;24:1040–1044
  50. Kurz H, Herbich K, Janata O, et al. Experience with the use of palivizumab together with infection control measures to prevent respiratory syncytial virus outbreaks in neonatal intensive care units. J Hosp Infect. 2008;70:246–252
  51. Jones BL, Clark S, Curran ET, et al. Control of an outbreak of respiratory syncytial virus infection in immunocompromised adults. J Hosp Infect. 2000;44:53–57
  52. Sorvillo FJ, Huie SF, Strassburg MA, et al. An outbreak of respiratory syncytial virus pneumonia in a nursing home for the elderly. J Infect. 1984;9:252–256
  53. Huang F-L, Chen P-Y, Shi ZY, et al. An unusual respiratory syncytial virus nosocomial outbreak in an adult psychiatry ward. Jpn J Infect Dis. 2009;62:61–62
  54. Caram LB, Chen J, Taggart EW, et al. Respiratory syncytial virus outbreak in a long-term care facility detected using reverse transcriptase polymerase chain reaction: an argument for real-time detection methods. J Am Geriatr Soc. 2009;57:482–485

 Financial disclosure: See Acknowledgments on page 1270.

PII: S1083-8791(10)00116-3

doi: 10.1016/j.bbmt.2010.03.011

Biology of Blood and Marrow Transplantation
Volume 16, Issue 9 , Pages 1265-1271 , September 2010

Article Tools

* Image Usage & Resolution